Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors

被引:118
作者
Short, JJ
Pereboev, AV
Kawakami, Y
Vasu, C
Holterman, MJ
Curiel, DT
机构
[1] Univ Alabama, Gene Therapy Ctr, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Pathol, Div Human Gene Therapy, Birmingham, AL 35294 USA
[4] Univ Alabama, Dept Surg, Div Human Gene Therapy, Birmingham, AL 35294 USA
[5] Univ Illinois, Dept Surg, Chicago, IL 60612 USA
[6] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA
关键词
adenovirus; receptor; CD80; CD86; subgroup B; co-stimulatory molecules;
D O I
10.1016/j.virol.2004.02.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Most viruses exploit a variety of host cellular proteins as primary cellular attachment receptors in the context of successful execution of infection. Furthermore, many viral agents have evolved precise mechanisms to subvert host immune recognition to achieve persistence. Herein we present data indicating that adenovirus (Ad) serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. CD80 and CD86 are co-stimulatory molecules that are present on mature dendritic cells and B lymphocytes and are involved in stimulating T-lymphocyte activation. To our knowledge, this is one of the first demonstrations of a virus utilizing immunologic accessory molecules as a primary means of cellular entry. This finding suggests a mechanism whereby viral exploitation of these proteins as receptors may achieve both goals of cellular entry and evading the immune system. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 49 条
[31]   The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F [J].
Roelvink, PW ;
Lizonova, A ;
Lee, JGM ;
Li, Y ;
Bergelson, JM ;
Finberg, RW ;
Brough, DE ;
Kovesdi, I ;
Wickham, TJ .
JOURNAL OF VIROLOGY, 1998, 72 (10) :7909-7915
[32]   Update an adenovirus and its vectors [J].
Russell, WC .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :2573-2604
[33]   Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector [J].
Sakurai, F ;
Mizuguchi, H ;
Hayakawa, T .
GENE THERAPY, 2003, 10 (12) :1041-1048
[34]  
SASLONE B, 2003, J VIROL, V77, P13448
[35]   Adenovirus type 11 uses CD46 as a cellular receptor [J].
Segerman, A ;
Atkinson, JP ;
Marttila, M ;
Dennerquist, V ;
Wadell, G ;
Arnberg, N .
JOURNAL OF VIROLOGY, 2003, 77 (17) :9183-9191
[36]   There are two different species B adenovirus receptors: sBAR, common to species B1 and B2 adenoviruses, and sB2AR, exclusively used by species B2 adenoviruses [J].
Segerman, A ;
Arnberg, N ;
Erikson, A ;
Lindman, K ;
Wadell, G .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1157-1162
[37]   Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines [J].
Segerman, A ;
Mei, YF ;
Wadell, G .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1457-1467
[38]   HUMAN ADENOVIRUS SEROTYPE-3 AND SEROTYPE-5 BIND TO 2 DIFFERENT CELLULAR RECEPTORS VIA THE FIBER HEAD DOMAIN [J].
STEVENSON, SC ;
ROLLENCE, M ;
WHITE, B ;
WEAVER, L ;
MCCLELLAND, A .
JOURNAL OF VIROLOGY, 1995, 69 (05) :2850-2857
[39]   Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein [J].
Stevenson, SC ;
Rollence, M ;
MarshallNeff, J ;
McClelland, A .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4782-4790
[40]   Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma [J].
Suvas, S ;
Singh, V ;
Sahdev, S ;
Vohra, H ;
Agrewala, JN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (10) :7766-7775